Affordable Access

[The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years].

Authors
  • Lipczyńska-Łojkowska, Wanda
  • Ryglewicz, Danuta
  • Jedrzejczak, Tomasz
  • Jakubowska, Teresa
  • Kotapka-Minc, Sławomira
  • Sienkiewicz-Jarosz, Halina
  • Bochyńska, Anna
Type
Published Article
Journal
Neurologia i neurochirurgia polska
Publication Date
Jan 01, 2004
Volume
38
Issue
6
Pages
471–481
Identifiers
PMID: 15654671
Source
Medline
License
Unknown

Abstract

From the investigations carried out it follows that treatment with rivastigmine during 24 months prevents a decrease of rCBF in patients with AD. However, the cognitive functions deteriorate after 24 months.

Report this publication

Statistics

Seen <100 times